
Invert provides a unified platform that turns complex bioprocess time-series data into faster, more confident decisions. It unifies data from instruments, sites, and CDMOs into AI-ready datasets, with built-in visualization, analytics, and a transparent AI interface. The product targets biotech, pharma, and manufacturing customers as a B2B SaaS solution and centers on core technologies for time-series processing and AI-enabled insights. Invert aims to reduce uncertainty, accelerate development and scale-up, and enable faster delivery of therapies and sustainable products at scale.

Invert provides a unified platform that turns complex bioprocess time-series data into faster, more confident decisions. It unifies data from instruments, sites, and CDMOs into AI-ready datasets, with built-in visualization, analytics, and a transparent AI interface. The product targets biotech, pharma, and manufacturing customers as a B2B SaaS solution and centers on core technologies for time-series processing and AI-enabled insights. Invert aims to reduce uncertainty, accelerate development and scale-up, and enable faster delivery of therapies and sustainable products at scale.